[
    [
        {
            "time": "",
            "original_text": "【光大医药|Q1点评】同仁堂：北京地区影响较为严重，母公司与科技双下滑",
            "features": {
                "keywords": [
                    "光大医药",
                    "Q1点评",
                    "同仁堂",
                    "北京地区",
                    "母公司",
                    "科技",
                    "双下滑"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【光大医药|Q1点评】同仁堂：北京地区影响较为严重，母公司与科技双下滑",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]